The ATS PAR hosted the Patients & Experts Forum, featuring expert insights and a patient perspective

ATS thanks Genentech, Inc., Insmed Incorporated, and United Therapeutics for their generous support of the ATS 2025 Patients & Experts Forum

🔗 Learn more: https://www.atsconferencenews.org/patients-experts-forum-prioritizes-patients-with-exploration-of-personalized-medicine/?utm_source=bluesky&utm_medium=social&utm_campaign=ATS-2025-Issue3-assoc-bluesky-share&utm_content=link-share